Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Assets Average (2016 - 2025)

Historic Assets Average for Mimedx (MDXG) over the last 15 years, with Q3 2025 value amounting to $305.0 million.

  • Mimedx's Assets Average rose 2869.24% to $305.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.0 million, marking a year-over-year increase of 2869.24%. This contributed to the annual value of $251.5 million for FY2024, which is 2253.11% up from last year.
  • According to the latest figures from Q3 2025, Mimedx's Assets Average is $305.0 million, which was up 2869.24% from $280.8 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Assets Average ranged from a high of $305.0 million in Q3 2025 and a low of $169.8 million during Q1 2023
  • Moreover, its 5-year median value for Assets Average was $189.0 million (2021), whereas its average is $209.9 million.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 1129.25% in 2021, then soared by 3567.22% in 2024.
  • Quarter analysis of 5 years shows Mimedx's Assets Average stood at $184.2 million in 2021, then fell by 6.57% to $172.1 million in 2022, then grew by 24.36% to $214.0 million in 2023, then grew by 18.63% to $253.9 million in 2024, then rose by 20.14% to $305.0 million in 2025.
  • Its last three reported values are $305.0 million in Q3 2025, $280.8 million for Q2 2025, and $267.2 million during Q1 2025.